Actinogen Medical

Actinogen Medical Tangible Book Value per Share

The Tangible Book Value per Share of Actinogen Medical (ACW.AX) as of Nov 1, 2026 is 0.01 AUD. In the previous year, Tangible Book Value per Share was 0.01 AUD — a change of 29.11% (higher).

Tangible Book Value per Share

0.01AUD

YoY

29.11%

Last updated:

Tangible Book Value per Share of Actinogen Medical is 2026 0.01 AUD. Tangible Book Value per Share of Actinogen Medical was 2025 0.01 AUD. It decreases by 29.11% higher compared to the previous year.

The Actinogen Medical Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2019
0.00 AUD
Jan 1, 2020
0.00 AUD
Jan 1, 2021
0.00 AUD
Jan 1, 2022
0.01 AUD
Jan 1, 2023
0.00 AUD
Jan 1, 2024
0.01 AUD
Jan 1, 2025
0.01 AUD
Jan 1, 2026
0.01 AUD
The Actinogen Medical Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
0.01AUD+29.11%
0.01AUD-5.95%
0.01AUD+60.03%
0.00AUD-42.17%
0.01AUD+31.85%
0.00AUD+91.25%
0.00AUD-37.17%
0.00AUD-5.98%
0.00AUD+182.33%
0.00AUD-34.73%
0.00AUD-29.34%
0.00AUD+709.14%
0.00AUD-89.30%
0.00AUD-48.65%
0.01AUD-82.21%
0.04AUD-16.47%
0.05AUD-38.90%
0.08AUD-34.22%
0.12AUD+977.39%
0.01AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Actinogen Medical Stock analysis

What does Actinogen Medical do? Actinogen Medical Ltd, based in Sydney, Australia, is a clinical-stage biotechnology company operating in the Health Care sector. It focuses on developing novel treatments for cognitive impairment linked to neurological, psychiatric, and metabolic diseases caused by elevated cortisol levels. The company's lead compound, Xanamem, targets the 11B-HSD1 enzyme in the brain to reduce cortisol, with ongoing Phase II studies for Alzheimer’s Disease, Major Depressive Disorder, and Fragile X Syndrome. The firm has conducted research involving approximately 300 volunteers and patients. Actinogen Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Actinogen Medical stock

Tangible Book Value per Share of Actinogen Medical is 0.01 AUD in 2026.

Tangible Book Value per Share of Actinogen Medical changed from 0.01 AUD to 0.01 AUD, representing a 29.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Actinogen Medical since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Actinogen Medical

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Actinogen Medical